Home/Filings/4/0001437749-20-003172
4//SEC Filing

Latkin Jed 4

Accession 0001437749-20-003172

CIK 0000810509other

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 4:39 PM ET

Size

4.2 KB

Accession

0001437749-20-003172

Insider Transaction Report

Form 4
Period: 2020-02-20
Latkin Jed
Interim COO
Transactions
  • Purchase

    Common Stock

    2020-02-20$1.08/sh+5,000$5,40017,950 total

Issuer

NAVIDEA BIOPHARMACEUTICALS, INC.

CIK 0000810509

Entity typeother

Related Parties

1
  • filerCIK 0001554593

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 4:39 PM ET
Size
4.2 KB